{"name":"Next Life Sciences","slug":"next-life-sciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPQUEwaE1ocmZSemcydEFUdG9fN2VNOWNIRGpobFQtSVBFVGJmczFSR2JlSk11STREUzU4OHZDSlBxSENET1g5QTFjWXZnN2xjSVZzQzFxem5UM1J1WkJKZTRMWGdHOTJ6Z25JODJwWE9tRFItMzJtRnppYjMzSkdBb095NDZCakM0TU1DUm5TRQ?oc=5","date":"2026-03-03","type":"pipeline","source":"New Jersey Business & Industry Association","summary":"HINJ Life Sciences Summit to Focus on NJ’s Pharma and Medtech Future - New Jersey Business & Industry Association","headline":"HINJ Life Sciences Summit to Focus on NJ’s Pharma and Medtech Future - New Jersey Business & Industry Association","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOSG52cTVjOGRJcEt0X0JhMXdPSC1BeVp1NFhXenQ1cS1xaEtkdWZnWV9KdjA5OFhmX3FKOFVWalFnZldPNW1BS01kei1rOW9xRmI0THlNMC1YVDk2N2V5bFlEcFJSRndaRHpHMlNwSzNfTHBZUU1XRm5ZczV3VmtxaDBYV2RXQWFXRG9aaFlWWEVSRUlnZVlfQkRJOXFaUE56Mk1rMTBhUWl4UXN5S1pGMDhIOFlRTjJLTFI3V3ZKOTRKcjlaSGVCLQ?oc=5","date":"2026-02-22","type":"trial","source":"BioPharma APAC","summary":"NEXT Life Sciences Advances Two Non Hormonal Male Contraceptives Into Phase II Trials - BioPharma APAC","headline":"NEXT Life Sciences Advances Two Non Hormonal Male Contraceptives Into Phase II Trials","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-17","type":"pipeline","source":"BusinessLine","summary":"Next round of growth in pharma, life sciences will be in high value products: CEOs - BusinessLine","headline":"Next round of growth in pharma, life sciences will be in high value products: CEOs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNM2tQVzBMeVpKVmpKRTVrM0RWd01jLU40aEV2S1lEX1cySFEwclVHQVFCV3hCNzlNd3JNeTVLeFpQYUxjYmdLQ0RtUmhja2NlTXRzeW80dHJsUmFtQk81OHpPbkRvNnllby1SM08wVzJMN0pwcHBEZXc5bkhvZ01xb2JZQk5jYWduTFFHTmdOV1FxRW9kWFRWSEpMeHB4RmNtdzlBT3dR?oc=5","date":"2026-02-06","type":"pipeline","source":"live.handelsblatt.com","summary":"How AI is transforming the future of pharma | Deloitte Future Talk Podcast - live.handelsblatt.com","headline":"How AI is transforming the future of pharma | Deloitte Future Talk Podcast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9oLXpPRDVnVzVzLU5NUDZoQVk1eUpHQm43d0ExNlF6TnJYVWFFVEF4RzBHSmFaTFVOVTBPOEt5ZHdMU0wtTFlSME93ZXljRG5JWXBFTmpwRU9zM0pzNlJKdg?oc=5","date":"2026-01-27","type":"pipeline","source":"Netguru","summary":"What Will the Life Sciences Industry Look Like in 2025? - Netguru","headline":"What Will the Life Sciences Industry Look Like in 2025?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-16","type":"pipeline","source":"The Times of India","summary":"Revanth to unveil Telangana’s next-gen life sciences policy at Davos - The Times of India","headline":"Revanth to unveil Telangana’s next-gen life sciences policy at Davos","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-15","type":"pipeline","source":"The New Indian Express","summary":"Telangana targets $250 bn life sciences economy by 2030 - The New Indian Express","headline":"Telangana targets $250 bn life sciences economy by 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNazh2WTVKU1lfWmVSNjRONVFmTUh1TDZycU5CSGU0Q3ZCSW4yM0VONjktemk2QlRhdFFPaUFFdW5zQjZXWmxNaFcySlFTc05DRFVQcjg2b1pyYk1EbG92cDZWTXNkalJENGZ1bnRGTl9jUDBJMFVXa2hrbllyTkoxQ05HUEswZUtXNk16TmhvNWJvdG1RWXVINQ?oc=5","date":"2026-01-09","type":"pipeline","source":"pwc.com","summary":"Future of Pharma: Breakthroughs at Scale - pwc.com","headline":"Future of Pharma: Breakthroughs at Scale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOYUhoVWtuNFd5WXpMVlBpWEhHWGdKSWVnNDhLWHRkSi1sVzRCRXZUcFp5ZlQ1ak9haXowSERrM0dkb3A2ZllnSlpHcjFxQ3BfUmhRXy01aDNuOWxBZVlfZTFTbWJWQjBONm0yb3BuOWNTaTFxN21HUDFoTzlBOVF0WDBDMThNbF9ndHhVeWZ4djZ2dHB2Ny15ZGdmU0ZMdXJIa1lrb1hGSVBqRDBC?oc=5","date":"2026-01-09","type":"pipeline","source":"TechTarget","summary":"5 trends defining the next wave of life sciences M&A - TechTarget","headline":"5 trends defining the next wave of life sciences M&A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE83VldBbWlBY0lkZU13QlkxVjZEQnVDUEl4aGJscWpwWHVnU05GVlRhZnVSazBfYjBYTl9WYVZwQncwSXJEMHVkSGgtZDRnTkZrSmtxRUZxMHVBT0FLa2lFUmpQbGlnLVpzaURSS3g2dU1uV3JKYzhZWXFn?oc=5","date":"2025-11-17","type":"pipeline","source":"Fierce Pharma","summary":"2025's Fiercest Women in Life Sciences - Fierce Pharma","headline":"2025's Fiercest Women in Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNNTkteHJNWGpKN2dwTkluWWpNUE12d1FHVElva19LVGFZRWM4cmdkdWJ0bm5iVkV3SDVqQ0JsbXdoaWg4NHZINm9rWTN3NHpRcU5aMXlpbVN5REpZSHN0dl9uTmlCUl93ZklTLTZGbjVOM3F0eDh2RC1WY2xHTEx6TC1lTVpodUlHUE9lUXZaUXhSa1NzY3VHcXZfQjA3YV9CWVNWZEcybExUQmJjYnc?oc=5","date":"2025-10-16","type":"pipeline","source":"Pharmaceutical Technology","summary":"From Nobel to next-gen: Sweden’s quiet life sciences ascent - Pharmaceutical Technology","headline":"From Nobel to next-gen: Sweden’s quiet life sciences ascent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPd0NPQm53bkVSNnptbEFrUkpsZEsxemY4MFY0aEhoU1Vjd216a3NmWkdYWHRndUpraGZqQjhJV1dTcUN1MUZULWtEeWNDVXVNdDFlVEJwWEFnSGU2Qm5DSFdJUDBsQ0RBUDJWUE1kVXBJTWNTT2g4NGxocEQ5RWtLWklYNGlUQWZLWVBTOWg5M2dGY19ZNlU3bkFoMi1GYjBBVlBoWjFMQ3lONTZzZHBfdnpJdUZFUXplWnZVM2tjMkt5Z0lzc3VnMlc5R3pvdm5TZ1F1ZnZuN29DQmttamh2Y25aNlAxY0hxUTFfYm4yQ3BaeTZ3S1hhNnZPM1M?oc=5","date":"2025-09-16","type":"pipeline","source":"A&O Shearman","summary":"Life after separation: what the future holds for pharma companies and their divested consumer healthcare divisions - A&O Shearman","headline":"Life after separation: what the future holds for pharma companies and their divested consumer healthcare divisions - A&O","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}